73 related articles for article (PubMed ID: 24632066)
1. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
2. Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19.
Hou L; Zhao Y; Zhao S; Zhang X; Yao X; Yang J; Wang Z; Chan ECY; Liu S
Chem Biol Interact; 2024 Jan; 387():110811. PubMed ID: 37993078
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein.
Court MH; Mealey KL; Burke NS; Jimenez TP; Zhu Z; Wakshlag JJ
J Vet Pharmacol Ther; 2024 Jan; 47(1):1-13. PubMed ID: 37469115
[TBL] [Abstract][Full Text] [Related]
4. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions.
Qin Z; Jia M; Yang J; Xing H; Yin Z; Yao Z; Zhang X; Yao X
Chin Med; 2020; 15():69. PubMed ID: 32655683
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.
Yin H; Wang Z; Lv X; Wang Z; Wang Y; Fan W; Li S; Jiang L; Cao J; Liu Y
Chem Biol Interact; 2024 May; 395():111023. PubMed ID: 38677539
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
7. The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.
VandenBrink BM; Isoherranen N
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):66-77. PubMed ID: 20047147
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
Fowler S; Zhang H
AAPS J; 2008 Jun; 10(2):410-24. PubMed ID: 18686042
[TBL] [Abstract][Full Text] [Related]
9. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.
Yadav J; Paragas E; Korzekwa K; Nagar S
Pharmacol Ther; 2020 Feb; 206():107449. PubMed ID: 31836452
[TBL] [Abstract][Full Text] [Related]
11. In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms.
Kim D; Zheng YF; Min JS; Park JB; Bae SH; Yoon KD; Chin YW; Oh E; Bae SK
Toxicol Lett; 2016 Sep; 259():1-10. PubMed ID: 27462006
[TBL] [Abstract][Full Text] [Related]
12. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.
Myers AP; Watson TA; Strock SB
Pharmacotherapy; 2015 Mar; 35(3):e9-e12. PubMed ID: 25756365
[TBL] [Abstract][Full Text] [Related]
13. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
Cho YY; Jeong HU; Kim JH; Lee HS
Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of ginsenoside Rh2 and Rg3 epimers after oral administration of BST204, a purified ginseng dry extract, in rats.
Bae SH; Park JB; Zheng YF; Jang MJ; Kim SO; Kim JY; Yoo YH; Yoon KD; Oh E; Bae SK
Xenobiotica; 2014 Dec; 44(12):1099-107. PubMed ID: 24933530
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.
Ben-Eltriki M; Shankar G; Tomlinson Guns ES; Deb S
Cancer Chemother Pharmacol; 2023 Dec; 92(6):419-437. PubMed ID: 37709921
[TBL] [Abstract][Full Text] [Related]
16. Benzisothiazolinone: Pharmacokinetics, Tissue Distribution, and Mass Balance Studies in Rats.
Jo SJ; Bae SH; Huang Z; Lee S; Lee CB; Chae SU; Park JB; Kwon M; Chung HK; Bae SK
Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233625
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of Renshen-Fuzi herb pair for treating heart failure-Integrating a cardiovascular pharmacological assessment with serum metabolomics.
Chen X; Chen Y; Xie S; Wang X; Wu Y; Zhang H; Zhao Y; Jia J; Wang B; Li W; Tang J; Xiao X
Front Pharmacol; 2022; 13():995796. PubMed ID: 36545315
[No Abstract] [Full Text] [Related]
18. Dietary supplements, cytochrome metabolism, and pharmacogenetic considerations.
Matura JM; Shea LA; Bankes VA
Ir J Med Sci; 2022 Oct; 191(5):2357-2365. PubMed ID: 34734388
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Efficacy and Safety of the Herbal Formula PM014 in a Cisplatin- and Paclitaxel-Treated Tumor-Bearing Mouse Model.
Lee C; Jeong H; Lee KH; Park S; Gang MJ; Bae SK; Bae H
Integr Cancer Ther; 2020; 19():1534735420924711. PubMed ID: 32590912
[TBL] [Abstract][Full Text] [Related]
20. Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone.
Zheng YF; Bae SH; Huang Z; Chae SU; Jo SJ; Shim HJ; Lee CB; Kim D; Yoo H; Bae SK
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32272615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
